Family Medicine · Cape Girardeau, MO
NPI
1598902728
Since 2009
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3129 Blattner Dr
Cape Girardeau, MO, 63703
Phone (573) 335-0166
Groups this clinician bills Medicare through
Medicare paid, 2024
$263K
5,249 services
Medicare patients, 2024
450
Average age 75
Drug cost, 2024
$2.3M
27,329 prescriptions
Company payments, 2025
$1,541
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James R Palen was code 99308 (snf e&m), 1,160 times for 194 patients. In total James R Palen billed 5,249 services in 53 codes, and Medicare paid $263K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 1,160 | 194 | $47.57 | $55K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,103 | 263 | $42.54 | $47K |
| 99214 Office E&M - Established | Office | 941 | 213 | $75.23 | $71K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 776 | 192 | $11.37 | $8,824 |
| 99233 Hospital E&M - Subsequent | Facility | 264 | 44 | $80.55 | $21K |
| 99309 SNF E&M | Office | 248 | 99 | $71.66 | $18K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 183 | 30 | $0.75 | $137 |
| 99306 SNF E&M | Office | 170 | 126 | $122.98 | $21K |
| 83037 Blood Count | Office | 51 | 38 | $9.52 | $486 |
| 99223 Hospital E&M - Initial | Facility | 39 | 31 | $120.65 | $4,705 |
| 99215 Office E&M - Established | Office | 38 | 27 | $104.59 | $3,974 |
| 99238 Hospital Discharge Management | Facility | 30 | 23 | $56.12 | $1,684 |
| 20610 Joint Injection | Office | 30 | 23 | $41.83 | $1,255 |
| 99315 SNF E&M | Office | 27 | 26 | $54.32 | $1,467 |
| 96372 Injection Administration | Office | 26 | 22 | $7.26 | $189 |
By year: 2022 $208K for 3,580 services; 2023 $250K for 4,091 services; 2024 $263K for 5,249 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83037 Blood Count | 51 | 38 | $9.52 | $486 |
| 81002 Clinical Chemistry | 18 | 15 | $3.41 | $61.38 |
Medicare prescription drug claims, 2024
In 2024, the drug James R Palen prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,089 prescriptions and refills. In total James R Palen wrote 27,329 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,089 | 1,091 | 138 | $25K |
| Levothyroxine Sodium Generic | 844 | 1,079 | 96 | $6,817 |
| Gabapentin Generic | 840 | 986 | 106 | $12K |
| Furosemide Generic | 832 | 989 | 119 | $4,708 |
| Atorvastatin Calcium Generic | 713 | 841 | 95 | $7,247 |
| Pantoprazole Sodium Generic | 645 | 811 | 99 | $6,828 |
| Rosuvastatin Calcium Generic | 587 | 741 | 65 | $8,252 |
| Amlodipine Besylate Generic | 580 | 847 | 92 | $3,865 |
| Lisinopril Generic | 480 | 727 | 64 | $3,348 |
| Metoprolol Succinate Generic | 460 | 561 | 59 | $5,619 |
| Metformin Hcl Generic | 449 | 661 | 65 | $3,389 |
| Metoprolol Tartrate Generic | 370 | 449 | 50 | $3,320 |
| Potassium Chloride Generic | 367 | 405 | 54 | $6,309 |
| Buspirone Hcl Generic | 353 | 365 | 34 | $5,166 |
| Tramadol Hcl Generic | 352 | 366 | 64 | $2,764 |
Brand drugs: 3,408 claims; generic drugs: 23,779 claims; opioid claims: 1,882.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James R Palen $1,541 ($1,541 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $293.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $293 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $187 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $174 |
| Lundbeck LLC | 5 | $82.34 |
| Lilly USA, LLC LLY | 4 | $66.33 |
| Exact Sciences Corporation EXAS | 4 | $65.87 |
| Viatris Specialty LLC | 4 | $65.19 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $60.13 |
| Verona Pharma, Inc. VRNA | 3 | $53.07 |
| Novo Nordisk Inc NVO | 3 | $50.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.